Performance dan Interface Testing pada Situs Toko Online Tokopedia dan Lazada

Abstrak – Maraknya berbagai aplikasi dengan fitur yang ditawarkan membuat banyak pengembang yang memanfaatkan hal ini dan membantu berbagai pekerjaan menjadi lebih mudah. Salah satunya adalah toko online. Bidang yang berkaitan erat dengan E-Commerce ini sedang ramai-ramainya dibicarakan, karena sebagian besar pengunjungnya adalah pengguna smartphone atau laptop. Namun ketika menggunakan aplikasi ini, tentunya pengunjung harus merasa nyaman saat mengaksesnya. Kenyamanan itu membuat mereka seringkali tidak menyadari terjadinya kesalahan yang tidak kasat mata. Sehingga diperlukan suatu pengujian untuk mengetahui letak kekurangan pada aplikasi tersebut. Para penulis akan menggunakan beberapa tools dimana nantinya akan menunjukkan hasil nyata tentang performansi dan kelayakan tampilan antarmuka dari aplikasi toko online yang akan diuji untuk mengetahui tingkat performansi situs tersebut.Kata Kunci: perfomansi, tampilan antarmuka, e-commerceAbstract – There are so many applications with features that makes programmers helps many jobs to be easier. One of them is online shop. This thing that is related with something called E-Commerce which has already been the headline this decade. It’s because most of their visitors are smartphone and laptop users. But when they use this application, the user needs to fill confortable while accessing the website. That comfort make them didn’t realize any invisible bugs that happen at the moment. So the applications must have a trial to know the weakness in the application. The writers will use some tools that will show the result about the performance and the proper interface from the one to be tested online shop application to know the level of performance of the site. Keywords: performance, interface, e-commerc

The Public Repository of Xenografts enables discovery and randomized phase II-like trials in mice

More than 90% of drugs with preclinical activity fail in human trials, largely due to insufficient efficacy. We hypothesized that adequately powered trials of patient-derived xenografts (PDX) in mice could efficiently define therapeutic activity across heterogeneous tumors. To address this hypothesis, we established a large, publicly available repository of well-characterized leukemia and lymphoma PDXs that undergo orthotopic engraftment, called the Public Repository of Xenografts (PRoXe). PRoXe includes all de-identified information relevant to the primary specimens and the PDXs derived from them. Using this repository, we demonstrate that large studies of acute leukemia PDXs that mimic human randomized clinical trials can characterize drug efficacy and generate transcriptional, functional, and proteomic biomarkers in both treatment-naive and relapsed/refractory disease